Patient Name: Damon Morton 
Age: 52

CC: Chest Pain

HPI: The patient is a 52-year-old male presenting to the emergency department with the chief complaint of chest pain. The pain started approximately 2 hours ago while the patient was at home and has been persistent. The patient describes the pain as a crushing sensation located in the center of his chest. He rates the pain as 8/10 and states that it radiates to his left arm. The pain is accompanied by sweating and shortness of breath. The patient denies any associated symptoms such as nausea, vomiting, or lightheadedness. He has no history of similar episodes in the past.

ROS:
- General: The patient reports feeling anxious and diaphoretic.
- Head: No headache or head injury reported.
- Eyes: No visual changes or eye pain reported.
- Cardiovascular: Denies palpitations or irregular heartbeat.
- Pulm: Denies cough or shortness of breath at rest.
- GI: No abdominal pain, nausea, or vomiting reported.
- GU: No urinary symptoms reported.
- Musculoskeletal: No joint pain or swelling reported.
- Neurologic: No numbness, weakness, or changes in speech reported.
- Endocrine: No history of diabetes or thyroid disorders reported.
- Skin: No rash or skin changes reported.

PMHx: The patient has a history of hypertension and hyperlipidemia. He is currently compliant with his medications.

Medications: 
- Lisinopril 10mg daily for hypertension
- Atorvastatin 20mg daily for hyperlipidemia

PSurgHx: No previous surgeries reported.

FamHx: The patient's father had a history of myocardial infarction in his 60s. No other significant family history reported.

SocHx: The patient is a non-smoker and denies any illicit drug use. He consumes alcohol occasionally in moderation. He currently works as an accountant and denies any recent changes in stress level or personal life events. He lives with his spouse and two adult children.

Given the patient's symptoms of crushing chest pain radiating to the left arm, associated sweating, and shortness of breath, there is concern for a possible acute coronary syndrome. Further evaluation and management will be initiated including cardiac biomarkers, EKG, and risk stratification.